Meridian Bioscience Posts 13 Percent Uptick in Q4 Revenues; 9 Percent FY13 Growth | GenomeWeb

NEW YORK (GenomeWeb News) — Meridian Bioscience today reported a 13 percent year-over-year increase in fiscal fourth quarter revenues and a 9 percent spike in full-year fiscal 2013 revenues.

For the three months ended Sept. 30, the Cincinnati, Ohio-based life science and clinical diagnostics firm reported fiscal Q4 revenues of $49 million, compared to $43.5 million in the year-ago period. Total FY2013 revenues were $188.7 million compared to $172.7 million in FY 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.